Search Results Search Sort by RelevanceMost Recent Medicine and Society Oct 2019 How Should Decision Aids Be Used During Counseling to Help Patients Who Are “Genetically at Risk”? Natalie Evans, PhD, Suzanne Metselaar, PhD, Carla van El, PhD, Nina Hallowell, DPhil, MA, and Guy Widdershoven, PhD Prognostic uncertainty about risk creates demand for ongoing communication and facilitated reflection about goals and values. AMA J Ethics. 2019;21(10):E865-872. doi: 10.1001/amajethics.2019.865. Medicine and Society Nov 2019 What Are Good Guidelines for Evaluating Uterus Transplantation? Margaret Horvat, MA and Ana Iltis, PhD Recent advances in UTx suggest it is on a trajectory toward becoming an accepted clinical practice to treat absolute uterine factor infertility. AMA J Ethics. 2019;21(11):E988-995. doi: 10.1001/amajethics.2019.988. Medicine and Society Nov 2019 What Hand Transplantation Teaches Us About Embodiment Brock Bahler, PhD Current QoL conversations in HTx could be enhanced by a phenomenological account of temporality, embodiment, and intersubjectivity. AMA J Ethics. 2019;21(11):E996-1002. doi: 10.1001/amajethics.2019.996. Policy Forum Nov 2019 Why Quality-of-Life Data Collection and Use Should Be Standardized When Evaluating Candidates for Hand Transplantation Martin Kumnig, PhD, MSc, Emma K. Massey, PhD, and Lisa S. Parker, PhD Improving candidate evaluation and informed consent is key to motivating authenticity, not just voluntariness. AMA J Ethics. 2019;21(11):E974-979. doi: 10.1001/amajethics.2019.974. State of the Art and Science Feb 2017 Reasonableness, Credibility, and Clinical Disagreement Mary Jean Walker, PhD and Wendy A. Rogers, BMBS, PhD When is a source credible and how do beliefs about a source’s credibility influence assessments of evidence? AMA J Ethics. 2017;19(2):176-182. doi: 10.1001/journalofethics.2017.19.2.stas1-1702. Policy Forum Feb 2017 What Is the Relevance of Procedural Fairness to Making Determinations about Medical Evidence? Govind Persad, JD, PhD Procedures for weighing factual evidence could help avoid the epistemic injustice of discounting or ignoring the voices of clinical research subjects. AMA J Ethics. 2017;19(2):183-191. doi: 10.1001/journalofethics.2017.19.2.pfor1-1702. Policy Forum Feb 2017 Seeking Legitimacy for DSM-5: The Bereavement Exception as an Example of Failed Process James E. Sabin, MD and Norman Daniels, PhD The DSM-5 Task Force’s handling of the ethical controversy over the bereavement exclusion demonstrates the need for more inclusive deliberative processes. AMA J Ethics. 2017;19(2):192-198. doi: 10.1001/journalofethics.2017.19.2.pfor2-1702. Medicine and Society Feb 2017 The Case of Dr. Oz: Ethics, Evidence, and Does Professional Self-Regulation Work? Jon C. Tilburt, MD, MPH, Megan Allyse, PhD, and Frederic W. Hafferty, PhD Dr. Oz’s advice has raised ethical questions about medicine as a profession, its evidentiary standards, and its role in maintaining public trust. AMA J Ethics. 2017;19(2):199-206. doi: 10.1001/journalofethics.2017.19.2.msoc1-1702. Health Law Jul 2019 Regional Unrepresented Patient Advocacy Committee as an Alternative for Decision Making Lisa K. Anderson-Shaw, DrPH, MA, MSN, ANP-BC A UPAC is an alternative to engaging a guardianship court appointment process or to using physicians or ethics committees as decision makers. AMA J Ethics. 2019;21(7):E594-599. doi: 10.1001/amajethics.2019.594. Case and Commentary Jul 2019 Should Aggregate Patient Preference Data Be Used to Make Decisions on Behalf of Unrepresented Patients? Nathaniel Sharadin, PhD, MA Ethical and practical problems with preference modeling can undermine how reliably predictors can be used in high-stakes decisions. AMA J Ethics. 2019;21(7):E566-574. doi: 10.1001/amajethics.2019.566. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Medicine and Society Oct 2019 How Should Decision Aids Be Used During Counseling to Help Patients Who Are “Genetically at Risk”? Natalie Evans, PhD, Suzanne Metselaar, PhD, Carla van El, PhD, Nina Hallowell, DPhil, MA, and Guy Widdershoven, PhD Prognostic uncertainty about risk creates demand for ongoing communication and facilitated reflection about goals and values. AMA J Ethics. 2019;21(10):E865-872. doi: 10.1001/amajethics.2019.865.
Medicine and Society Nov 2019 What Are Good Guidelines for Evaluating Uterus Transplantation? Margaret Horvat, MA and Ana Iltis, PhD Recent advances in UTx suggest it is on a trajectory toward becoming an accepted clinical practice to treat absolute uterine factor infertility. AMA J Ethics. 2019;21(11):E988-995. doi: 10.1001/amajethics.2019.988.
Medicine and Society Nov 2019 What Hand Transplantation Teaches Us About Embodiment Brock Bahler, PhD Current QoL conversations in HTx could be enhanced by a phenomenological account of temporality, embodiment, and intersubjectivity. AMA J Ethics. 2019;21(11):E996-1002. doi: 10.1001/amajethics.2019.996.
Policy Forum Nov 2019 Why Quality-of-Life Data Collection and Use Should Be Standardized When Evaluating Candidates for Hand Transplantation Martin Kumnig, PhD, MSc, Emma K. Massey, PhD, and Lisa S. Parker, PhD Improving candidate evaluation and informed consent is key to motivating authenticity, not just voluntariness. AMA J Ethics. 2019;21(11):E974-979. doi: 10.1001/amajethics.2019.974.
State of the Art and Science Feb 2017 Reasonableness, Credibility, and Clinical Disagreement Mary Jean Walker, PhD and Wendy A. Rogers, BMBS, PhD When is a source credible and how do beliefs about a source’s credibility influence assessments of evidence? AMA J Ethics. 2017;19(2):176-182. doi: 10.1001/journalofethics.2017.19.2.stas1-1702.
Policy Forum Feb 2017 What Is the Relevance of Procedural Fairness to Making Determinations about Medical Evidence? Govind Persad, JD, PhD Procedures for weighing factual evidence could help avoid the epistemic injustice of discounting or ignoring the voices of clinical research subjects. AMA J Ethics. 2017;19(2):183-191. doi: 10.1001/journalofethics.2017.19.2.pfor1-1702.
Policy Forum Feb 2017 Seeking Legitimacy for DSM-5: The Bereavement Exception as an Example of Failed Process James E. Sabin, MD and Norman Daniels, PhD The DSM-5 Task Force’s handling of the ethical controversy over the bereavement exclusion demonstrates the need for more inclusive deliberative processes. AMA J Ethics. 2017;19(2):192-198. doi: 10.1001/journalofethics.2017.19.2.pfor2-1702.
Medicine and Society Feb 2017 The Case of Dr. Oz: Ethics, Evidence, and Does Professional Self-Regulation Work? Jon C. Tilburt, MD, MPH, Megan Allyse, PhD, and Frederic W. Hafferty, PhD Dr. Oz’s advice has raised ethical questions about medicine as a profession, its evidentiary standards, and its role in maintaining public trust. AMA J Ethics. 2017;19(2):199-206. doi: 10.1001/journalofethics.2017.19.2.msoc1-1702.
Health Law Jul 2019 Regional Unrepresented Patient Advocacy Committee as an Alternative for Decision Making Lisa K. Anderson-Shaw, DrPH, MA, MSN, ANP-BC A UPAC is an alternative to engaging a guardianship court appointment process or to using physicians or ethics committees as decision makers. AMA J Ethics. 2019;21(7):E594-599. doi: 10.1001/amajethics.2019.594.
Case and Commentary Jul 2019 Should Aggregate Patient Preference Data Be Used to Make Decisions on Behalf of Unrepresented Patients? Nathaniel Sharadin, PhD, MA Ethical and practical problems with preference modeling can undermine how reliably predictors can be used in high-stakes decisions. AMA J Ethics. 2019;21(7):E566-574. doi: 10.1001/amajethics.2019.566.